• 1
    Weaver M, Schnoll S. Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002;18(Suppl. 4):5619.
  • 2
    Chabal C, Erjavec MK, Jacobsen L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence and predictors. Clin J Pain 1997;13: 1505.
  • 3
    Manchikanti L, Pampati V, Damron K, et al. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001;4: 35865.
  • 4
    Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18(Suppl. 4): 52838.
  • 5
    Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11(4):20317.
  • 6
    Webster LR, Webster RM. Predicting Aberrant Drug-Related Behavior in Chronic Pain Patients. New York: International Conference on Pain and Chemical Dependency; 2002.
  • 7
    American Psychiatric Association. DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2001.
  • 8
    McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. J Nerv Ment Dis 1980;168: 2633.
  • 9
    McLellan AT, Luborsky L, Cacciola J, Griffith J. New data from the Addiction Severity Index: Reliability and validity in three centers. J Nerv Ment Dis 1985;173: 41223.
  • 10
    McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199213.
  • 11
    Spitzer RL, Williams JB, Mirian G, First M. Instruction Manual for the Structured Interview for DSM-III-R. New York: Biometrics Research Department, New York State Psychiatric Institute; 1989.
  • 12
    Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID) I: History, rationale and description. Arch Gen Psychiatry 1992;49: 6249.
  • 13
    Williams JB, Gibbon M, First M, et al. The structured clinical interview for DSM-III-R (SCID) II: Multisite test-retest reliability. Arch Gen Psychiatry 1992;49: 6306.
  • 14
    Kranzler H, Kadden R, Babor TF, Tennen H, Rounsaville BJ. Validity of the SCID in substance abuse patients. Addiction 1996;91: 85968.
  • 15
    Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA 1984;252: 19057.
  • 16
    Atluri S, Sudarshan G. A screening tool to determine the risk of prescription opioid abuse among patients with chronic non-malignant pain. Pain Phys 2002;5: 4.
  • 17
    Brown RL, Leonard T, Saunders LA, Papasouliotis O. A two-item screening test for alcohol and other drug problems. J Fam Pract 1997;44: 15160.
  • 18
    Butler SF, Budman SH, Fernandez K, Benoit C, Jamison RN. Validation of a screener and opioid assessment for patients with pain. Poster Presented to the 6th International Conference on Pain and Chemical Dependency, Brooklyn, NY; 2004.
  • 19
    Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and a “problematic” substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16(6):35563.
  • 20
    Bastiaens L, Riccardi K, Sakhrani D. The RAFFT as a screening tool for adult substance use disorders. Am J Drug Alcohol Abuse 2002;28(4):68393.
  • 21
    Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict 1989;84: 3017.
  • 22
    Sutherland G, Edwards G, Taylor C, et al. The measurement of opiate dependence. Br J Addict 1986;81: 48394.
  • 23
    Meller WH, Rinehart R, Cadoret RJ, Troughton E. Specific familial transmission in substance abuse. Int J Addict 1988;23(10):102939.
  • 24
    Tsuang MT, Lyons MJ, Eisen SA, et al. Genetic influences on DSM-III-R drug abuse and dependence: A study of 3,372 twin pairs. Am J Med Genet 1996;67: 4737.
  • 25
    Jang KL, Livesley WJ, Vernon PA. Alcohol and drug problems: A multivariate behavioural genetic analysis of comorbidity. Addiction 1995;90: 121321.
  • 26
    Lewis DC, ed. Personality pathology, family history of alcoholism linked. DATA: The Brown University of Addiction Theory and Application 1999;18:3.
  • 27
    Prescott CA, Aggen SH, Kendler KS. Sex-specific genetic influences on the comorbidity of alcoholism and major depression in a population-based sample of US twins. Arch Gen Psychiatry 2000;57: 80311.
  • 28
    Schuckit MA. Biological, psychological and environmental predictors of the alcoholism risk: A longitudinal study. J Stud Alcohol 1998;59: 48594.
  • 29
    Tsuang MT, Lyons MJ, Meyer JM, et al. Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulner-abilities. Arch Gen Psychiatry 1998;55: 96772.
  • 30
    Zickler P. Twin studies help define the role of genes in vulnerability to drug abuse. NIDA Notes 1999;14(4).
  • 31
    Belcher S, Shinitzky HE. Substance abuse in children: Prediction, protection, prevention. Arch Pediatr Adolesc Med 1998;152(10): 95260.
  • 32
    Prescott CA. Sex Differences in the Genetic Risk for Alcoholism. National Institute on Alcohol Abuse and Alcoholism (NIAAA) Publications 2003. Available at: (accessed November 2003).
  • 33
    Bohman M. Some genetic aspects of alcoholism and criminality: A population of adoptees. Arch Gen Psychiatry 1978;35: 26976.
  • 34
    Goodwin DW. Alcoholism and genetics: The sins of the fathers. Arch Gen Psychiatry 1985;42: 1714.
  • 35
    Staines GL, Magura S, Foote J, Deluca A, Kosanke N. Polysubstance abuse among alcoholics. J Addict Dis 2001;20: 5369.
  • 36
    Lewis DC, ed. Study: Abusers of one drug are at risk of abusing others. DATA: The Brown University Digest of Addiction Theory and Application 1999;18:3.
  • 37
    Substance abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings. Rockville, MD: Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964, 2004.
  • 38
    Burke JD, Burke KC, Rae DS. Increased rates of drug abuse and dependence after onset of mood or anxiety disorders in adolescence. Hosp Community Psychiatry 1994;45: 5.
  • 39
    Christie KA, Burke JD, Jr., Regier DA, et al. Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. Am J Psychiatry 1988;145(8):9715.
  • 40
    Horowitz HA, Overton WF, Rosenstein D, Steidl JH. Comorbid adolescent substance abuse: A maladaptive pattern of self-regulation. Adolesc Psychiatry 1992;18: 46583.
  • 41
    Ross HE, Glaser FB, Glaser MD, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988;45: 102331.
  • 42
    Kendler KS, Bulik CM, Silberg J, et al. Childhood sexual abuse and adult psychiatric and substance use disorders in women: An epidemiological and co-twin control analysis. Arch Gen Psychiatry 2000;57(10):9539.
  • 43
    Lewis DC, ed. Dual diagnosis: Patients report interplay of substance use, PTSD symptoms. DATA: The Brown University Digest of Addiction Theory and Application 1999;18(3).
  • 44
    Mullen PE, Martin JL, Anderson JC, Romans SE, Herbison GP. Childhood sexual abuse and mental health in adult life. Br J Psychiatry 1993;163: 72132.
  • 45
    Zickler P. Childhood sex abuse increases risk for drug dependence in adult women. NIDA Notes 2002;17(1).
  • 46
    Bifulco A, Brown GW, Adler Z. Early sexual abuse and clinical depression in adult life. Br J Psychiatry 1991;159: 11522.
  • 47
    Swan N. Exploring the role of child abuse in later drug abuse. NIDA Notes 1998;13(2).
  • 48
    Farrell M, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Br J Psychiatry 2001;179: 4327.
  • 49
    Merikangas KR, Gelernter CS. Comorbidity for alcoholism and depression. Psychiatr Clin North Am 1990;13(4):61322.
  • 50
    Schuckit MA. New findings in the genetics of alcoholism. JAMA 1999;281(20):18756.
  • 51
    Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug use. JAMA 1990; 264(19):25118.
  • 52
    Stocker S. Medications reduce incidence of substance abuse among ADHD patients. NIDA Notes 1999;14(4).
  • 53
    Webster L. Assessing abuse potential in pain patients. Medscape Neurol Neurosurg 2004;6(1).
  • 54
    Conover WJ. Practical Nonparametric Statistics. 2nd edition. New York: John Willey & Sons; 1980:1659.
  • 55
    Harrell FE Jr. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression and Survival Analysis. New York: Springer-Verlag; 2001.
  • 56
    Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd edition. New York: John Wiley & Sons; 2000.
  • 57
    Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist Med 1996;15: 36187.
  • 58
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: A nonparametric approach. Biometrics 1988;44: 83745.
  • 59
    Rothman KJ. Epidemiology: An Introduction. Oxford: Oxford University Press; 2002:112.
  • 60
    Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. New York: Oxford University Press; 1995.
  • 61
    Passik SD, Kirsh KL. Commentary: The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med 2003;4(2):1858.
  • 62
    Passik SD, Kirsh KL, Whitcomb LA, Dickerson P, Theobald DE. Pain clinicians’ rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother 2002;16(4):3949.